Managing Trace Elements in Parenteral Nutrition
A new website providing educational content and treatment guidelines
Dedicated to Alleviating Drug Shortages
We are committed to collaborating with the FDA to prevent or mitigate drug shortages that impact the health of patients.
Check Product Availability
Updated May 29, 2023
American Regent® Launches Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)
Melville, NY – May 2, 2023: American Regent® is pleased to announce the launch of Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)
American Regent introduces FDA-approved Epinephrine Injection, USP
Melville, NY – March 23, 2023: American Regent announces the launch of sulfite-free Epinephrine Injection, USP.
HBT Labs, Inc. to Join American Regent, Inc
Shirley, NY – American Regent, Inc., a U.S. manufacturer of pharmaceuticals for human and veterinary use with manufacturing sites in New York and Ohio, today announced it acquired HBT Labs, Inc. based in California.